| Common Stock, Shares Authorized |
2,000,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
500,000 |
shares |
499900% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$13,592 |
USD |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$7,646 |
USD |
2182% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$7,646 |
USD |
2182% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$49,500 |
USD |
3005% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |